|
|
Title | Creator | Description | Identifier |
1 |
|
Visual Impairment in Patients with Giant Cell Arteritis Treated with Tocilizumab in Real-World Clinical Practice | Timothy McCulley; Jinglan Pei; Paris Sidiropoulos; Christine Birchwood; Jennie Best; John Stone; Sebastian Unizony | The GiACTA trial demonstrated the efficacy of tocilizumab (TCZ) in giant cell arteritis (GCA) [1]. However, the effectiveness of TCZ for prevention of specific GCA-related visual manifestations is currently unknown. The incidence of GCA-related visual manifestations was analyzed in patients treated ... | 20190319_nanos_sciplatform3_08-video |
2 |
|
Visual Impairment in Patients with Giant Cell Arteritis Treated with Tocilizumab in Real-World Clinical Practice | Timothy McCulley; Jinglan Pei; Paris Sidiropoulos; Christine Birchwood; Jennie Best; John Stone; Sebastian Unizony | The GiACTA trial demonstrated the efficacy of tocilizumab (TCZ) in giant cell arteritis (GCA) [1]. However, the effectiveness of TCZ for prevention of specific GCA-related visual manifestations is currently unknown. The incidence of GCA-related visual manifestations was analyzed in patients treated ... | 20190319_nanos_sciplatform3_08_slides |
3 |
|
Visual Impairment in Patients with Giant Cell Arteritis Treated with Tocilizumab in Real-World Clinical Practice | Timothy McCulley; Jinglan Pei; Paris Sidiropoulos; Christine Birchwood; Jennie Best; John Stone; Sebastian Unizony | The GiACTA trial demonstrated the efficacy of tocilizumab (TCZ) in giant cell arteritis (GCA) [1]. However, the effectiveness of TCZ for prevention of specific GCA-related visual manifestations is currently unknown. The incidence of GCA-related visual manifestations was analyzed in patients treated ... | 20190319_nanos_sciplatform3_08-abstract |